Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=216"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=216

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01772472-deaths",
        "title": "Trastuzumab vs Trastuzumab Emtansine: deaths from any cause",
        "summary": "126 of 743 against 94 of 743; risk difference 4.3 points, 95% interval 0.7 to 7.9; NCT01772472, A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)",
        "record": "/library/comparisons/NCT01772472-deaths",
        "nct_id": "NCT01772472",
        "kind": "deaths",
        "participants": 1486,
        "risk_difference": {
          "value": 0.04306864064602961,
          "lower": 0.006927949834620084,
          "upper": 0.07920283408365097
        },
        "group_1": "126 of 743",
        "group_2": "94 of 743",
        "difference": "4.3 points",
        "interval": "0.7 to 7.9",
        "trial_title": "A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)"
      },
      {
        "id": "NCT02866175-deaths",
        "title": "Edoxaban Regimen vs Vitamin K Antagonist Regimen: deaths from any cause",
        "summary": "46 of 746 against 37 of 740; risk difference 1.2 points, 95% interval -1.2 to 3.5; NCT02866175, Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention",
        "record": "/library/comparisons/NCT02866175-deaths",
        "nct_id": "NCT02866175",
        "kind": "deaths",
        "participants": 1486,
        "risk_difference": {
          "value": 0.011662198391420908,
          "lower": -0.011964616657909561,
          "upper": 0.03547391470628197
        },
        "group_1": "46 of 746",
        "group_2": "37 of 740",
        "difference": "1.2 points",
        "interval": "-1.2 to 3.5",
        "trial_title": "Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=217",
  "request_id": "XI_h9KIBxUFMan6f"
}